Iranian Journal of Pediatrics

Published by: Kowsar

Serotype, Genotype, and Clinical Manifestations of Group B Streptococcus (GBS) Isolated from Neonates in China

Shaohua Wang 1 , * , Li Li 1 , Benqing Wu 2 and Weiyuan Wu 3
Authors Information
1 Neonatal Intensive Care Unit, Women and Children Health Institute Futian, University of South China, Shenzhen, China
2 Neonatal Department, Shenzhen People’s Hospital, Shenzhen, China
3 Laboratory Department, Shenzhen People’s Hospital, Shenzhen, China
Article information
  • Iranian Journal of Pediatrics: February 2018, 28 (1); e14580
  • Published Online: February 7, 2018
  • Article Type: Research Article
  • Received: June 7, 2017
  • Revised: September 4, 2017
  • Accepted: January 1, 2018
  • DOI: 10.5812/ijp.14580

To Cite: Wang S, Li L, Wu B, Wu W. Serotype, Genotype, and Clinical Manifestations of Group B Streptococcus (GBS) Isolated from Neonates in China, Iran J Pediatr. 2018 ; 28(1):e14580. doi: 10.5812/ijp.14580.

Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Davies HD, Adair CE, Partlow ES, Sauve R, Low DE, McGeer A. Two-year survey of Alberta laboratories processing of antenatal group B streptococcal (GBS) screening specimens: implications for GBS screening programs. Diagn Microbiol Infect Dis. 1999;35(3):169-76. doi: 10.1016/S0732-8893(99)00076-0. [PubMed: 10626125].
  • 2. Votava M, Tejkalova M, Drabkova M, Unzeitig V, Braveny I. Use of GBS media for rapid detection of group B streptococci in vaginal and rectal swabs from women in labor. Eur J Clin Microbiol Infect Dis. 2001;20(2):120-2. doi: 10.1007/s10096-001-8060-5. [PubMed: 11305465].
  • 3. Verani JR, McGee L, Schrag SJ, Division of Bacterial Diseases NCFI, Respiratory Diseases CFDC.Prevention. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36. [PubMed: 21088663].
  • 4. Chu SM, Hsu JF, Lee CW, Lien R, Huang HR, Chiang MC, et al. Neurological complications after neonatal bacteremia: the clinical characteristics, risk factors, and outcomes. PLoS One. 2014;9(11). e105294. doi: 10.1371/journal.pone.0105294. [PubMed: 25364821].
  • 5. Narava S, Rajaram G, Ramadevi A, Prakash GV, Mackenzie S. Prevention of perinatal group B streptococcal infections: a review with an Indian perspective. Indian J Med Microbiol. 2014;32(1):6-12. doi: 10.4103/0255-0857.124286. [PubMed: 24399380].
  • 6. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, et al. Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol. 2004;42(1):146-50. doi: 10.1128/JCM.42.1.146-150.2004. [PubMed: 14715745].
  • 7. Poyart C, Reglier-Poupet H, Tazi A, Billoet A, Dmytruk N, Bidet P, et al. Invasive group B streptococcal infections in infants, France. Emerg Infect Dis. 2008;14(10):1647-9. doi: 10.3201/eid1410.080185. [PubMed: 18826837].
  • 8. Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80(2):212-4. doi: 10.1016/j.mimet.2009.11.010. [PubMed: 19958797].
  • 9. Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS, Kunst F, et al. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol. 2003;41(6):2530-6. doi: 10.1128/JCM.41.6.2530-2536.2003. [PubMed: 12791877].
  • 10. Tettelin H, Masignani V, Cieslewicz MJ, Donati C, Medini D, Ward NL, et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A. 2005;102(39):13950-5. doi: 10.1073/pnas.0506758102. [PubMed: 16172379].
  • 11. Tazi A, Bellais S, Tardieux I, Dramsi S, Trieu-Cuot P, Poyart C. Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr Opin Microbiol. 2012;15(1):44-9. doi: 10.1016/j.mib.2011.12.002. [PubMed: 22206860].
  • 12. Manning SD, Springman AC, Lehotzky E, Lewis MA, Whittam TS, Davies HD. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol. 2009;47(4):1143-8. doi: 10.1128/JCM.01424-08. [PubMed: 19158264].
  • 13. Lartigue MF, Kostrzewa M, Salloum M, Haguenoer E, Hery-Arnaud G, Domelier AS, et al. Rapid detection of "highly virulent" Group B Streptococcus ST-17 and emerging ST-1 clones by MALDI-TOF mass spectrometry. J Microbiol Methods. 2011;86(2):262-5. doi: 10.1016/j.mimet.2011.05.017. [PubMed: 21663770].
  • 14. Alkuwaity K, Taylor A, Heckels JE, Doran KS, Christodoulides M. Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro. PLoS One. 2012;7(8). e42660. doi: 10.1371/journal.pone.0042660. [PubMed: 22900037].
  • 15. Murayama SY, Seki C, Sakata H, Sunaoshi K, Nakayama E, Iwata S, et al. Capsular type and antibiotic resistance in Streptococcus agalactiae isolates from patients, ranging from newborns to the elderly, with invasive infections. Antimicrob Agents Chemother. 2009;53(6):2650-3. doi: 10.1128/AAC.01716-08. [PubMed: 19332682].
  • 16. Frohlicher S, Reichen-Fahrni G, Muller M, Surbek D, Droz S, Spellerberg B, et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med Wkly. 2014;144:w13935. doi: 10.4414/smw.2014.13935. [PubMed: 24652673].
  • 17. Chen Y, Zhang L, Yang Q, Wu S. Study on perinatal group B Streptococcus carriers in late pregnancy and analysis of drug resistance. J Trop Med. 2015:1387-9.
  • 18. Liakopoulos A, Mavroidi A, Vourli S, Panopoulou M, Zachariadou L, Chatzipanagiotou S, et al. Molecular characterization of Streptococcus agalactiae from vaginal colonization and neonatal infections: a 4-year multicenter study in Greece. Diagn Microbiol Infect Dis. 2014;78(4):487-90. doi: 10.1016/j.diagmicrobio.2013.12.017. [PubMed: 24503505].
  • 19. Gherardi G, Imperi M, Baldassarri L, Pataracchia M, Alfarone G, Recchia S, et al. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy. J Clin Microbiol. 2007;45(9):2909-16. doi: 10.1128/JCM.00999-07. [PubMed: 17634303].
  • 20. Gygax SE, Schuyler JA, Kimmel LE, Trama JP, Mordechai E, Adelson ME. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. Antimicrob Agents Chemother. 2006;50(5):1875-7. doi: 10.1128/AAC.50.5.1875-1877.2006. [PubMed: 16641466].
  • 21. Cherkaoui A, Emonet S, Fernandez J, Schorderet D, Schrenzel J. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of Beta-hemolytic streptococci. J Clin Microbiol. 2011;49(8):3004-5. doi: 10.1128/JCM.00240-11. [PubMed: 21697322].
  • 22. Li-Min L, Xian-Hua WU, Li-Feng XU, Hospital QP. Drug resistance and clinical infection distribution of Streptococcus agalactiae. Chinese J Nosocomiol. 2014;24(3):549-51.
  • 23. Dagnew AF, Cunnington MC, Dube Q, Edwards MS, French N, Heyderman RS, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis. 2012;55(1):91-102. doi: 10.1093/cid/cis395. [PubMed: 22523262].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments